Variant report
Variant | esv1796618 |
---|---|
Chromosome Location | chr6:63543977-63592539 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150745275 | chr6:63543991-63543992 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139077268 | chr6:63544023-63544024 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538912300 | chr6:63544042-63544043 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554323536 | chr6:63544046-63544047 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544328546 | chr6:63544060-63544061 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562410361 | chr6:63544061-63544062 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189344124 | chr6:63544066-63544067 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554626659 | chr6:63544067-63544068 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs61314736 | chr6:63544070-63544071 | Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs181939076 | chr6:63544087-63544088 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs369965263 | chr6:63544127-63544128 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs149407630 | chr6:63544199-63544200 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112567137 | chr6:63544201-63544202 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540901374 | chr6:63544234-63544235 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541582515 | chr6:63544242-63544243 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527799497 | chr6:63544258-63544259 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542662273 | chr6:63544261-63544262 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559904840 | chr6:63544278-63544279 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560953915 | chr6:63544293-63544294 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144777318 | chr6:63544315-63544316 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527626439 | chr6:63544324-63544325 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571877038 | chr6:63544337-63544338 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532828659 | chr6:63544349-63544350 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139773892 | chr6:63544372-63544373 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566250074 | chr6:63544389-63544390 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536356356 | chr6:63544390-63544391 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185642768 | chr6:63544421-63544422 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144503343 | chr6:63544456-63544457 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536674537 | chr6:63544463-63544464 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs117749838 | chr6:63544469-63544470 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370742799 | chr6:63544500-63544501 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552165176 | chr6:63544510-63544511 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375388879 | chr6:63544511-63544512 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529044354 | chr6:63544517-63544518 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs146559188 | chr6:63544528-63544529 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570856427 | chr6:63544533-63544534 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577078416 | chr6:63544543-63544544 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541291105 | chr6:63544559-63544560 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552892695 | chr6:63544564-63544565 | Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574249232 | chr6:63544602-63544603 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541612983 | chr6:63544609-63544610 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9360883 | chr6:63544610-63544611 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs559904294 | chr6:63544623-63544624 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9360884 | chr6:63544649-63544650 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs565250952 | chr6:63544653-63544654 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs116333558 | chr6:63544658-63544659 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568517701 | chr6:63544661-63544662 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190162796 | chr6:63544687-63544688 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs9341509 | chr6:63544703-63544704 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs368690936 | chr6:63544722-63544723 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:63543000-63544600 | Genic enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:63544600-63545800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr6:63545800-63556600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:63556600-63560400 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr6:63560400-63561800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:63561800-63563000 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr6:63563000-63572400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:63571800-63572400 | ZNF genes & repeats | Monocytes-CD14+_RO01746 | blood |
9 | chr6:63572400-63572600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr6:63572600-63579600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:63579600-63582400 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:63582400-63589200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:63589200-63591800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr6:63591800-63596800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |